References
- WHO. WHO | Medicines and health products. WHO. https://www.who.int/activities/promoting-rational-use-of-medicines (2019) Accessed 25 Dec 2019.
- Ofori-Asenso R, Agyeman AA. Irrational use of medicines-a summary of key concepts. Pharm (Basel, Switzerland). 2016;4(4):35.
- WHO. How to investigate drug use in health facilities. Select Drug Use Indic. 1993;7:92.
- Milton JC, Hill-Smith I, Jackson SHD. Prescribing for older people. BMJ. 2008;336(7644):606–9.
- Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.
- Ansari J. Drug interaction and pharmacist. J Young Pharm. 2010;2(3):326–31.
- Barot PA, Malhotra SD, Patel VJ. Evaluation of potential drug-drug interactions in patients of emergency medicine department at a Tertiary Care Teaching Hospital: a prospective study. Int J Sci Stud. 2015;5:9–14.
- United Nations. World Population Ageing 2017 - Highlights (ST/ESA/SER.A/397). 2017. 46 p. http://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2017_Highlights.pdf
- Cadogan CA, Ryan C, Hughes CM. Appropriate polypharmacy and medicine safety: when many is not too many. Drug Saf. 2016;39(2):109–16.
- Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):1–10.
- WHO. Multimorbidity. Technical Series on Safer Primary Care. World Health Organization. 2016. 28 p.
- Besdine RW. Introduction to Geriatrics - Geriatrics - MSD Manual Professional Edition. MSD Manual. https://www.msdmanuals.com/professional/geriatrics/approach-to-the-geriatric-patient/introduction-to-geriatrics (2013) Accessed 5 Jan 2019.
- Statistics South Africa. Media release: Social profile of older persons 2011–2015 report. p. 1–6. www.statssa.gov.za/?p=9698 (2018) Accessed 23 Jan 2020.
- Gorard DA. Escalating polypharmacy. QJM. 2006;99(11):797–800.
- Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol. 2008;65(3):396–406.
- Olsson S, Pal SN, Stergachis A, Couper M. Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis. Drug Saf. 2010;33(8):689–703.
- Kapp PA, Klop AC, Jenkins LS. Drug interactions in primary health care in the George subdistrict, South Africa: a cross-sectional study. South African Fam Pract. 2013;55(1):78–84.
- KwaZulu-Natal Department of Health. 2014/2015 KwaZulu-Natal health annual report. 2015.
- Rana D, Suthar J, Malhotra S, Patel V, Patel P. A study of potential adverse drug–drug interactions among prescribed drugs in medicine outpatient department of a tertiary care teaching hospital. J Basic Clin Pharm. 2014;5(2):44.
- Gunasekaran T, Dejene N, Satyaveni VV, Dhanaraju MD. Occurrence of drug–drug interactions in Adama Referral Hospital, Adama city. Ethiopia J Drug Assess. 2015;4(1):19–23.
- Clauson KA, Polen HH. Selecting the right online drug information database for your organization. Pharm Purch Prod. http://www.pppmag.com/documents/V4N8/p6_8_9_10.pdf (2007).
- Kheshti R, Aalipour M, Namazi S. A comparison of five common drug–drug interaction software programs regarding accuracy and comprehensiveness. J Res Pharm Pract. 2016;5(4):257.
- Roblek T, Vaupotic T, Mrhar A, Lainscak M. Drug-drug interaction software in clinical practice: a systematic review. Eur J Clin Pharmacol. 2015;71(2):131–42.
- Coondoo A, Chattopadhyay C. Drug interactions in dermatology: What the dermatologist should know. Indian J Dermatol. 2013;58(4):249.
- WHO. WHO | International Classification of Diseases (ICD) Information Sheet. WHO. http://www.who.int/classifications/icd/factsheet/en/index.html (2013) Accessed 16 Mar 2020.
- Hines LE, Murphy JE. Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother. 2011;9(6):364–77.
- Jazbar J, Locatelli I, Horvat N, Kos M. Clinically relevant potential drug–drug interactions among outpatients: a nationwide database study. Res Soc Adm Pharm. 2018;14(6):572–80. https://doi.org/10.1016/j.sapharm.2017.07.004.
- McHugh ML. The chi-square test of independence. Biochem medica. 2013;23(2):143–9.
- Dancey CP, Reidy JG, Rowe R. Statistics for the health sciences: a non-mathematical introduction. p. 563. https://play.google.com/books/reader?id=4NSCAgAAQBAJ&printsec=frontcover&pg=GBS.PP1 (2012) Accessed 10 Aug 2020.
- Epocrates I. Frequently Asked Questions and Helpful Hints. https://online.epocrates.com/noFrame/help.jsp (2021) Accessed 20 May 2021.
- Truven Health Analytics Inc. Drug Interactions Severity Definitions. https://www.micromedexsolutions.com/micromedex2/4.34.0/WebHelp/Tools/Interactions/Drug_Interactions_severity_definitions.htm (2013) Accessed 20 May 2021.
- Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci. 2006;9(3):427–33.
- Pradhan S, Panda A, Mohanty M, Behera J, Ramani Y, Pradhan P. A study of the prevalence of potentially inappropriate medication in elderly in a tertiary care teaching hospital in the state of Odisha. Int J Med Public Health. 2015;5(4):344.
- Shah BM, Hajjar ER. Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med. 2012;28(2):173–86. https://doi.org/10.1016/j.cger.2012.01.002.
- Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010. BMC Med. 2015;13(1):74. https://doi.org/10.1186/s12916-015-0322-7.
- Accetta RC. Polypharmacy: strategies for reducing the consequences of multiple medications. Today’s Geriatr Med. 2016;9(3):24.
- Metzgar MA. Strategies for Reducing Polypharmacy in Senior Care | MedPro Group. https://www.medpro.com/senior-care-polypharmacy Accessed 20 May 2021.
- Stewart RB, Cooper JW. Polypharmacy in the aged. Drugs Aging. 1994;4(6):449–61. https://doi.org/10.2165/00002512-.199404060-00002.
- Nguyen T, Wong E, Ciummo F. Polypharmacy in older adults: practical applications alongside a patient case. J Nurse Pract. 2020. https://doi.org/10.1016/j.nurpra.2019.11.017.
- The Department of Health. National Drug Policy for South Africa. 1994;1–31.